Showing results (1321-1330 of 1,955) with videos related to

Sort By:
Pageof 196
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 1, 2015
Chicago Ebola Response Network (CERN): A Citywide Cross-hospital Collaborative for Infectious Disease PreparednessOmar Lateef, Bala Hota, Emily Landon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2006
Randomized phase II study of interleukin-12 in combination with rituximab in previously treated non-Hodgkin's lymphoma patientsStephen M Ansell, Susan M Geyer, Matthew J Maurer, et al.
Journal of the National Cancer Institute|January 22, 2004
Retention of enrollees following a cancer diagnosis within health maintenance organizations in the Cancer Research NetworkTerry S Field, Jackie Cernieux, Diana Buist, et al.
Blood|September 17, 2011
Comprehensive analysis of tumor microenvironment cytokines in Waldenstrom macroglobulinemia identifies CCL5 as a novel modulator of IL-6 activitySherine F Elsawa, Anne J Novak, Steven C Ziesmer, et al.
Regulatory Toxicology and Pharmacology : RTP|August 1, 2006
Report of an ISRTP workshop: progress and barriers to incorporating alternative toxicological methods in the U.SRichard A Becker, Christopher J Borgert, Simon Webb, et al.
Nature Materials|January 15, 2013
Singular phase nano-optics in plasmonic metamaterials for label-free single-molecule detectionV G Kravets, F Schedin, R Jalil, et al.
Journal for Immunotherapy of Cancer|June 24, 2022
Nivolumab in patients with relapsed or refractory peripheral T-cell lymphoma: modest activity and cases of hyperprogressionN Nora Bennani, Hyo Jin Kim, Levi D Pederson, et al.
British Journal of Cancer|September 29, 2020
The impact of a supranetwork multidisciplinary team (SMDT) on decision-making in testicular cancers: a 10-year overview of the Anglian Germ Cell Cancer Collaborative Group (AGCCCG)Jonathan Shamash, Wendy Ansell, Constantine Alifrangis, et al.
Oral and Maxillofacial Surgery|January 17, 2025
Non-smoking, non-drinking, oral squamous cell carcinoma patients are a distinct and clinically significant groupPaul Mario Capanni, Jeremey David McMahon, Bilal Aslam-Pervez, et al.
The Lancet. Haematology|July 5, 2016
Everolimus combined with R-CHOP-21 for new, untreated, diffuse large B-cell lymphoma (NCCTG 1085 [Alliance]): safety and efficacy results of a phase 1 and feasibility trialPatrick B Johnston, Betsy LaPlant, Ellen McPhail, et al.
Pageof 196